Back
Eton Pharmaceuticals Quote, Financials, Valuation and Earnings
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
56
ETON
Eton Pharmaceuticals
Last Price:
8.29
Seasonality Move:
10.53%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Eton Pharmaceuticals Price Quote
$8.29
-0.06 (-3.83%)
(Updated: November 5, 2024 at 5:23 AM ET)
Eton Pharmaceuticals Key Stats
Buy
56
Eton Pharmaceuticals (ETON)
is a Buy
Day range:
$8.24 - $8.69
52-week range:
$3.03 - $9.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.85
P/B ratio:
16.03%
Volume:
87.3K
Avg. volume:
182.2K
1-year change:
83.52%
Market cap:
$215.7M
Revenue:
$31.6M
EPS:
$-0.26
How Much Does Eton Pharmaceuticals Make?
-
How Much Are Eton Pharmaceuticals's Sales Annually?
ETON Revenues are $31.6M -
How Much Profit Does Eton Pharmaceuticals's Make A Year?
ETON net income is -$936K
Is Eton Pharmaceuticals Growing As A Company?
-
What Is Eton Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.24% -
What Is Eton Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Eton Pharmaceuticals Stock Price Performance
-
Did Eton Pharmaceuticals Stock Go Up Last Month?
Eton Pharmaceuticals share price went up by 19.29% last month -
Did ETON's Share Price Rise Over The Last Year?
ETON share price rose by 83.52% over the past 1 year
What Is Eton Pharmaceuticals 52-Week High & Low?
-
What Is Eton Pharmaceuticals’s 52-Week High Share Price?
Eton Pharmaceuticals has traded as high as $9.12 over the past 52 weeks -
What Is Eton Pharmaceuticals’s 52-Week Low Share Price?
Eton Pharmaceuticals has traded as low as $3.03 over the past 52 weeks
Eton Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Eton Pharmaceuticals?
-
How Much Debt Does Eton Pharmaceuticals Have?
Total long term debt quarterly is $4.7M -
How Much Cash Does Eton Pharmaceuticals Have?
Cash and short term investments quarterly total is $17.7M -
What Is Eton Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.52
Is Eton Pharmaceuticals Cash Flow Positive?
-
What Is ETON Cash Flow From Operations?
Cash flow from operations (TTM) is $42K -
What Is Eton Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.3M -
What Is Eton Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.7M
Eton Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
ETON return on invested capital is -31.86% -
What Is Eton Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -21.32% -
What Is ETON Return On Equity?
ROE is a measure of profitability and is -42.84%
Eton Pharmaceuticals Earnings Date & Stock Price
-
What Is Eton Pharmaceuticals's Stock Price Today?
A single share of ETON can be purchased today for 8.35 -
What Is Eton Pharmaceuticals’s Stock Symbol?
Eton Pharmaceuticals trades on the nasdaq under the ticker symbol: ETON -
When Is Eton Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Eton Pharmaceuticals is scheduled on November 8, 2024 -
When Is ETON's next ex-dividend date?
Eton Pharmaceuticals's next ex-dividend date is May 16, 2020 -
How To Buy Eton Pharmaceuticals Stock?
You can buy Eton Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Eton Pharmaceuticals Competitors
-
Who Are Eton Pharmaceuticals's Competitors?
Below is a list of companies who compete with Eton Pharmaceuticals or are related in some way:
Eton Pharmaceuticals Dividend Yield
-
What Is ETON Dividend Yield?
Eton Pharmaceuticals’s dividend yield currently is 0% -
What Is Eton Pharmaceuticals’s Payout Ratio?
Eton Pharmaceuticals’s payout ratio is 0% -
When Did Eton Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Eton Pharmaceuticals’s Dividend Per Share?
Eton Pharmaceuticals pays a dividend of $0.00 per share
Eton Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -71.43% |
| Revenue: | -24.36% | 3.11% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 13.00 |
| Upside from Last Price: | 55.69% |